We are transforming from our established base in devices for extracorporeal circulation to develop as a comprehensive leader in blood-related healthcare systems, spanning from disease treatment to preventive medicine. Healthcare systems are also being developed in regenerative medicine, neurology, and other fields, and resources are proactively invested in manufacturing plants and R&D for global expansion.
|Trade name||Asahi Kasei Medical Co., Ltd.|
|Main businesses||APS™ artificial kidneys, Cellsorba™ leukocytapheresis column, Sepacell™ leukocyte reduction filters, Planova™ virus removal filters|
|Home office||1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo 101-8101 Japan|
|Paid-in capital||¥3,000 million|
|Shareholder||Asahi Kasei Corp.|